Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

LogicBio's initial public offering nets $74.9mm

Executive Summary

LogicBio Therapeutics Inc. (gene editing) netted $74.9mm through its initial public offering of 8mm common shares (including the overallotment) at $10. The company originally intended to sell 5.77mm shares for $12-14.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Transgenics
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies